|
US3887699A
(en)
|
1969-03-24 |
1975-06-03 |
Seymour Yolles |
Biodegradable polymeric article for dispensing drugs
|
|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
GB1502774A
(en)
|
1974-06-25 |
1978-03-01 |
Nat Res Dev |
Immunological preparations
|
|
US4242501A
(en)
|
1979-08-08 |
1980-12-30 |
American Cyanamid Company |
Purification of pneumococcal capsular polysaccharides
|
|
US4270537A
(en)
|
1979-11-19 |
1981-06-02 |
Romaine Richard A |
Automatic hypodermic syringe
|
|
PH19942A
(en)
|
1980-11-18 |
1986-08-14 |
Sintex Inc |
Microencapsulation of water soluble polypeptides
|
|
IE52535B1
(en)
|
1981-02-16 |
1987-12-09 |
Ici Plc |
Continuous release pharmaceutical compositions
|
|
US4436727A
(en)
|
1982-05-26 |
1984-03-13 |
Ribi Immunochem Research, Inc. |
Refined detoxified endotoxin product
|
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
US4987237A
(en)
|
1983-08-26 |
1991-01-22 |
Ribi Immunochem Research, Inc. |
Derivatives of monophosphoryl lipid A
|
|
DE3413608A1
(de)
|
1984-04-11 |
1985-10-24 |
Hoechst Ag, 6230 Frankfurt |
Implantierbare zubereitungen von regulatorischen peptiden mit gesteuerter freisetzung und verfahren zu ihrer herstellung
|
|
US4686102A
(en)
|
1984-04-12 |
1987-08-11 |
American Cyanamid Company |
Multivalent pneumococcal vaccine and preparation thereof
|
|
US5916588A
(en)
|
1984-04-12 |
1999-06-29 |
The Liposome Company, Inc. |
Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use
|
|
US6090406A
(en)
|
1984-04-12 |
2000-07-18 |
The Liposome Company, Inc. |
Potentiation of immune responses with liposomal adjuvants
|
|
US4596556A
(en)
|
1985-03-25 |
1986-06-24 |
Bioject, Inc. |
Hypodermic injection apparatus
|
|
EP0296158B1
(en)
|
1986-03-06 |
1992-06-17 |
Commonwealth Scientific And Industrial Research Organisation |
$i(IN VITRO) ASSAY FOR DETECTING CELL-MEDIATED IMMUNE RESPONSES
|
|
CA1283827C
(en)
|
1986-12-18 |
1991-05-07 |
Giorgio Cirelli |
Appliance for injection of liquid formulations
|
|
GB8704027D0
(en)
|
1987-02-20 |
1987-03-25 |
Owen Mumford Ltd |
Syringe needle combination
|
|
NZ224422A
(en)
|
1987-05-05 |
1990-11-27 |
Molecular Eng Ass |
Composition adapted for intranasal immunisation against viral infection comprising a glycoprotein complexed with a lipid
|
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
|
US4790824A
(en)
|
1987-06-19 |
1988-12-13 |
Bioject, Inc. |
Non-invasive hypodermic injection device
|
|
US4941880A
(en)
|
1987-06-19 |
1990-07-17 |
Bioject, Inc. |
Pre-filled ampule and non-invasive hypodermic injection device assembly
|
|
US4940460A
(en)
|
1987-06-19 |
1990-07-10 |
Bioject, Inc. |
Patient-fillable and non-invasive hypodermic injection device assembly
|
|
US5339163A
(en)
|
1988-03-16 |
1994-08-16 |
Canon Kabushiki Kaisha |
Automatic exposure control device using plural image plane detection areas
|
|
FR2638359A1
(fr)
|
1988-11-03 |
1990-05-04 |
Tino Dalto |
Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau
|
|
GB8906795D0
(en)
|
1989-03-23 |
1989-05-10 |
Carroll Noel |
Method of preparing vaccines
|
|
JPH0832638B2
(ja)
|
1989-05-25 |
1996-03-29 |
カイロン コーポレイション |
サブミクロン油滴乳剤を含んで成るアジュバント製剤
|
|
JPH0372423A
(ja)
|
1989-05-26 |
1991-03-27 |
Green Cross Corp:The |
パーフルオロカーボン化合物含有乳化製剤
|
|
US5064413A
(en)
|
1989-11-09 |
1991-11-12 |
Bioject, Inc. |
Needleless hypodermic injection device
|
|
US5312335A
(en)
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
US5190521A
(en)
|
1990-08-22 |
1993-03-02 |
Tecnol Medical Products, Inc. |
Apparatus and method for raising a skin wheal and anesthetizing skin
|
|
US5527288A
(en)
|
1990-12-13 |
1996-06-18 |
Elan Medical Technologies Limited |
Intradermal drug delivery device and method for intradermal delivery of drugs
|
|
CA2059692C
(en)
|
1991-01-28 |
2004-11-16 |
Peter J. Kniskern |
Pneumoccoccal polysaccharide conjugate vaccine
|
|
GB9118204D0
(en)
|
1991-08-23 |
1991-10-09 |
Weston Terence E |
Needle-less injector
|
|
SE9102652D0
(sv)
|
1991-09-13 |
1991-09-13 |
Kabi Pharmacia Ab |
Injection needle arrangement
|
|
US5371197A
(en)
|
1991-09-24 |
1994-12-06 |
Merck & Co., Inc. |
Protein-dimeric polysaccharide conjugate vaccine
|
|
US5328483A
(en)
|
1992-02-27 |
1994-07-12 |
Jacoby Richard M |
Intradermal injection device with medication and needle guard
|
|
US5383851A
(en)
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
US5674698A
(en)
|
1992-09-14 |
1997-10-07 |
Sri International |
Up-converting reporters for biological and other assays using laser excitation techniques
|
|
US5569189A
(en)
|
1992-09-28 |
1996-10-29 |
Equidyne Systems, Inc. |
hypodermic jet injector
|
|
US5334144A
(en)
|
1992-10-30 |
1994-08-02 |
Becton, Dickinson And Company |
Single use disposable needleless injector
|
|
US5500161A
(en)
|
1993-09-21 |
1996-03-19 |
Massachusetts Institute Of Technology And Virus Research Institute |
Method for making hydrophobic polymeric microparticles
|
|
GB9326253D0
(en)
|
1993-12-23 |
1994-02-23 |
Smithkline Beecham Biolog |
Vaccines
|
|
IL112372A
(en)
|
1994-02-07 |
2001-08-26 |
Res Dev Foundation |
Non-viral vector for the delivery of genetic information to cells
|
|
WO1995024176A1
(en)
|
1994-03-07 |
1995-09-14 |
Bioject, Inc. |
Ampule filling device
|
|
US5466220A
(en)
|
1994-03-08 |
1995-11-14 |
Bioject, Inc. |
Drug vial mixing and transfer device
|
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6429199B1
(en)
|
1994-07-15 |
2002-08-06 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules for activating dendritic cells
|
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US5565204A
(en)
|
1994-08-24 |
1996-10-15 |
American Cyanamid Company |
Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
|
|
US5599302A
(en)
|
1995-01-09 |
1997-02-04 |
Medi-Ject Corporation |
Medical injection system and method, gas spring thereof and launching device using gas spring
|
|
ATE241384T1
(de)
|
1995-03-22 |
2003-06-15 |
Jackson H M Found Military Med |
Herstellung von immunogenen konstrukten unter verwendung von löslichen kohlehydraten, die durch organische cyanylierungs-reagenzien aktiviert wurden
|
|
US5730723A
(en)
|
1995-10-10 |
1998-03-24 |
Visionary Medical Products Corporation, Inc. |
Gas pressured needle-less injection device and method
|
|
US5893397A
(en)
|
1996-01-12 |
1999-04-13 |
Bioject Inc. |
Medication vial/syringe liquid-transfer apparatus
|
|
ES2301175T3
(es)
|
1996-02-09 |
2008-06-16 |
Smithkline Beecham Biologicals S.A. |
Vacunas contra el producto del gen 63 del virus de la varicela zoster.
|
|
SE9600647D0
(sv)
|
1996-02-21 |
1996-02-21 |
Bror Morein |
Ny användning
|
|
GB9607549D0
(en)
|
1996-04-11 |
1996-06-12 |
Weston Medical Ltd |
Spring-powered dispensing device
|
|
PT942983E
(pt)
|
1996-10-31 |
2007-02-28 |
Human Genome Sciences Inc |
Antigénios e vacinas de streptococcus pneumoniae
|
|
AU753688B2
(en)
|
1997-03-10 |
2002-10-24 |
Ottawa Civic Loeb Research Institute |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
|
EP0977588B1
(en)
|
1997-04-24 |
2004-10-06 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Coupling of unmodified proteins to haloacyl or dihaloacyl derivatized polysaccharides for the preparation of protein-polysaccharide vaccines
|
|
US5993412A
(en)
|
1997-05-19 |
1999-11-30 |
Bioject, Inc. |
Injection apparatus
|
|
US6800744B1
(en)
|
1997-07-02 |
2004-10-05 |
Genome Therapeutics Corporation |
Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
|
|
EP0998557A2
(en)
|
1997-07-21 |
2000-05-10 |
North American Vaccine, Inc. |
Modified immunogenic pneumolysin, compositions and their use as vaccines
|
|
AU9310298A
(en)
|
1997-09-09 |
1999-03-29 |
Trustees Of Columbia University In The City Of New York, The |
T-independent conjugate-vaccines
|
|
US6562798B1
(en)
|
1998-06-05 |
2003-05-13 |
Dynavax Technologies Corp. |
Immunostimulatory oligonucleotides with modified bases and methods of use thereof
|
|
US20040247662A1
(en)
|
1998-06-25 |
2004-12-09 |
Dow Steven W. |
Systemic immune activation method using nucleic acid-lipid complexes
|
|
EP2053126A1
(en)
*
|
1998-07-27 |
2009-04-29 |
Sanofi Pasteur Limited |
Streptococcus pneumoniae proteins and nucleic acid molecules
|
|
JP2002521058A
(ja)
*
|
1998-07-27 |
2002-07-16 |
マイクロビアル テクニクス リミティッド |
肺炎連鎖球菌由来の核酸及びタンパク質
|
|
GB9817052D0
(en)
|
1998-08-05 |
1998-09-30 |
Smithkline Beecham Biolog |
Vaccine
|
|
DK1140157T3
(da)
|
1998-12-21 |
2009-06-08 |
Medimmune Inc |
Streptococcus pneumoniae-proteiner og immunogene fragmenter til vacciner
|
|
SE9900496D0
(sv)
|
1999-02-12 |
1999-02-12 |
Pharmatrix Ab |
Vaccine formulation
|
|
GB9928678D0
(en)
|
1999-12-03 |
2000-02-02 |
Provalis Uk Ltd |
Streptococcus pneumoniae antigens
|
|
US6398774B1
(en)
|
1999-09-29 |
2002-06-04 |
Heska Corporation |
Intranasal delivery system
|
|
US8246945B2
(en)
|
2000-04-06 |
2012-08-21 |
University Of Arkansas |
Methods and reagents for decreasing clinical reaction to allergy
|
|
US20020051794A1
(en)
|
2000-08-09 |
2002-05-02 |
Alk-Abello A/S |
Novel parenteral vaccine formulations and uses thereof
|
|
JP2004509970A
(ja)
|
2000-09-26 |
2004-04-02 |
ハイブリドン・インコーポレイテッド |
位置的化学変化による免疫刺激オリゴヌクレオチドアナログの免疫刺激活性の調節
|
|
SE0003538D0
(sv)
|
2000-09-29 |
2000-09-29 |
Isconova Ab |
New immunogenic complex
|
|
GB0107658D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Streptococcus pneumoniae
|
|
GB0118249D0
(en)
|
2001-07-26 |
2001-09-19 |
Chiron Spa |
Histidine vaccines
|
|
DE60234375D1
(de)
|
2001-09-14 |
2009-12-24 |
Cytos Biotechnology Ag |
VERPACKUNG VON IMMUNSTIMULIERENDEM CpG IN VIRUSÄHNLICHEN PARTIKELN: HERSTELLUNGSVERFAHREN UND VERWENDUNG
|
|
AU2002347404A1
(en)
|
2001-09-14 |
2003-04-01 |
Cytos Biotechnology Ag |
In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles
|
|
WO2003044185A2
(en)
|
2001-11-21 |
2003-05-30 |
Affinium Pharmaceuticals, Inc. |
Purified polypeptides involved in general metabolism
|
|
MXPA04011248A
(es)
|
2002-05-14 |
2005-02-17 |
Chiron Srl |
Vacunas mucosales en combinacion para la meningitis bacteriana.
|
|
SE0202110D0
(sv)
|
2002-07-05 |
2002-07-05 |
Isconova Ab |
Iscom preparation and use thereof
|
|
US20060121058A1
(en)
|
2002-08-08 |
2006-06-08 |
Children's Medical Center Corporation |
Anti-pneumococcal preparations
|
|
JP2006506989A
(ja)
|
2002-11-07 |
2006-03-02 |
シナジー アメリカ，インコーポレイテッド |
肺炎球菌感染を治療または予防するための組成物および方法
|
|
AU2002952548A0
(en)
|
2002-11-08 |
2002-11-21 |
Cellestis Limited |
Diagnostic assay
|
|
US20060251675A1
(en)
|
2003-03-17 |
2006-11-09 |
Michael Hagen |
Mutant cholera holotoxin as an adjuvant and an antigen carrier protein
|
|
JP2007525157A
(ja)
|
2003-04-15 |
2007-09-06 |
インターツェル・アクチェンゲゼルシャフト |
肺炎連鎖球菌抗原
|
|
BRPI0410423A
(pt)
|
2003-05-07 |
2006-06-06 |
Sanofi Pasteur Inc |
processo de imunogenicidade melhorada para vacinação meningocócica
|
|
SE0301998D0
(sv)
|
2003-07-07 |
2003-07-07 |
Isconova Ab |
Quil A fraction with low toxicity and use thereof
|
|
US20050013812A1
(en)
|
2003-07-14 |
2005-01-20 |
Dow Steven W. |
Vaccines using pattern recognition receptor-ligand:lipid complexes
|
|
GB0318688D0
(en)
|
2003-08-08 |
2003-09-10 |
Chiron Srl |
Streptococcus pneumoniae knockout mutants
|
|
JP5097400B2
(ja)
|
2003-09-03 |
2012-12-12 |
デンドリセラピューティクス、インク． |
複合ワクチン
|
|
US7786288B2
(en)
|
2003-10-23 |
2010-08-31 |
Karp Nelson M |
Immunizing compositions encoding an epitope obtained from the HIV-1 capsid protein cyclophilin A binding site
|
|
US20050181035A1
(en)
|
2004-02-17 |
2005-08-18 |
Dow Steven W. |
Systemic immune activation method using non CpG nucleic acids
|
|
US20050226899A1
(en)
|
2004-04-08 |
2005-10-13 |
Mauro Castiglioni |
Cosmetic mask composition
|
|
US20070128183A1
(en)
|
2004-04-27 |
2007-06-07 |
Intercell Ag |
Td antigens
|
|
GB0410220D0
(en)
|
2004-05-07 |
2004-06-09 |
Kirkham Lea Ann |
Mutant pneumolysin proteins
|
|
CA2576083A1
(en)
|
2004-08-18 |
2006-02-23 |
Joel Weiner |
Protein production method utilizing yebf
|
|
FI20041396A0
(fi)
|
2004-10-29 |
2004-10-29 |
Vesa Pekka Hytoenen |
Uudet mikrobiavidiinit
|
|
GB0428394D0
(en)
|
2004-12-24 |
2005-02-02 |
Chiron Srl |
Saccharide conjugate vaccines
|
|
BRPI0606481A2
(pt)
|
2005-01-20 |
2009-06-30 |
Isconova Ab |
composição de vacina compreendendo uma proteìna de ligação a fibronectina ou um peptìdeo de ligação a fibronectina
|
|
WO2006084466A2
(en)
|
2005-02-11 |
2006-08-17 |
Ace Biosciences A/S |
Surface-located streptococcus pneumoniae polypeptides
|
|
US20090148894A1
(en)
|
2005-08-15 |
2009-06-11 |
Broedel Sheldon E |
Methods for optimizing the secretion of protein in prokaryotes
|
|
CA2621023C
(en)
|
2005-09-01 |
2019-07-02 |
Novartis Vaccines And Diagnostics Gmbh & Co. Kg |
Multiple vaccination including serogroup c meningococcus
|
|
KR20080090411A
(ko)
|
2005-12-08 |
2008-10-08 |
유니버시티 오브 루이빌 리서치 파운데이션, 인코포레이티드 |
면역자극 조성물 및 방법
|
|
WO2007081583A2
(en)
|
2006-01-04 |
2007-07-19 |
Children's Medical Center Corporation |
Anti-pneumococcal preparations and methods of use
|
|
US7943133B2
(en)
|
2006-02-02 |
2011-05-17 |
Boston Biocom Llc |
Mesothelin antibody protein fusions and methods of use
|
|
WO2007098186A2
(en)
|
2006-02-22 |
2007-08-30 |
Novavax, Inc. |
Adjuvant and vaccine compositions
|
|
US20080032340A1
(en)
|
2006-06-09 |
2008-02-07 |
University Of Arizona |
Peptide motifs for binding avidin or neutravidin
|
|
US8148084B2
(en)
|
2006-06-22 |
2012-04-03 |
Dana-Farber Cancer Institute, Inc. |
Diagnosis of autoimmune disease
|
|
CA2690973A1
(en)
|
2006-06-23 |
2007-12-27 |
Paul M. Simon |
Targeted immune conjugates
|
|
US7452985B2
(en)
|
2006-08-17 |
2008-11-18 |
Visgeneer, Inc. |
Human Ron-related gene variant associated with cancers
|
|
WO2008033966A2
(en)
|
2006-09-12 |
2008-03-20 |
Alphavax, Inc. |
Alphavirus replicon particles matched to protein antigens as immunological adjuvants
|
|
EP2066346B1
(en)
|
2006-09-12 |
2019-07-03 |
AlphaVax, Inc. |
Alphavirus replicon particles encoding il-12 as immunological adjuvants
|
|
WO2008058035A1
(en)
|
2006-11-03 |
2008-05-15 |
Alphavax, Inc. |
Alphavirus and alphavirus replicon particle formulations and methods
|
|
EP2089515A4
(en)
|
2006-11-16 |
2011-02-23 |
Novavax Inc |
VIRUSUAL PARTICLES OF RESPIRATORY SYNZYTIAL VIRUS
|
|
EP2104512A2
(en)
|
2006-12-21 |
2009-09-30 |
Emergent Product Development UK Limited |
Streptococcus proteins, and their use in vaccination
|
|
CN100579152C
(zh)
|
2007-01-29 |
2010-01-06 |
华为技术有限公司 |
一种播放集团彩铃的方法、系统及装置
|
|
EP2468869B1
(en)
|
2007-01-31 |
2015-03-18 |
Pfenex Inc. |
Bacterial leader sequences for increased expression
|
|
WO2008119358A2
(en)
|
2007-03-30 |
2008-10-09 |
Ace Biosciences A/S |
Surface-located streptococcus pneumoniae polypeptides for use in vaccine compositions
|
|
BRPI0810211A2
(pt)
|
2007-04-13 |
2014-10-21 |
Univ Oklahoma |
Citolisina dependente de colesterol mutante purficada, composição, vacina, método para vacinar um paciente, anticorpo monoclonal, ácido nucléico, e, célula hospedeira.
|
|
MX2009013949A
(es)
|
2007-06-26 |
2010-05-24 |
Glaxosmithkline Biolog Sa |
Vacuna que comprende conjugados de polisacárido capsular de streptococcus pneumoniae.
|
|
GB0714963D0
(en)
*
|
2007-08-01 |
2007-09-12 |
Novartis Ag |
Compositions comprising antigens
|
|
WO2009021548A1
(en)
|
2007-08-10 |
2009-02-19 |
Wacker Chemie Ag |
Expression of full length igg and secretion into the culture medium of prokaryotic cells
|
|
AU2008292897B2
(en)
|
2007-08-31 |
2015-01-22 |
University Of Chicago |
Methods and compositions related to immunizing against staphylococcal lung diseases and conditions
|
|
US20090068288A1
(en)
|
2007-09-07 |
2009-03-12 |
Wayne Kruger |
Topical antiseptic veterinary solution
|
|
US9125863B2
(en)
|
2008-05-22 |
2015-09-08 |
Children's Medical Center Corporation |
Synergistic immunogenic fusion protein-polysaccharide conjugate
|
|
WO2010078027A1
(en)
|
2008-12-17 |
2010-07-08 |
Genocea Biosciences, Inc. |
Chlamydia antigens and uses thereof
|
|
EP2376526A4
(en)
|
2008-12-24 |
2013-02-27 |
Kingdom Of The Netherlands Represented By The Min Ister Of Health Welfare & Sport On Behalf Of The M |
MODIFIED STREPTOCOCCUS PNEUMONIAE PNEUMOLYSIN (PLY) POLYPEPTIDE
|
|
EP2208787A1
(en)
|
2009-01-19 |
2010-07-21 |
Université de Liège |
A recombinant alpha-hemolysin polypeptide of Staphylococcus aureus, having a deletion in the stem domain and heterologous sequences inserted
|
|
US8828953B2
(en)
|
2009-04-20 |
2014-09-09 |
NaZura BioHealth, Inc. |
Chemosensory receptor ligand-based therapies
|
|
AU2010249330B2
(en)
|
2009-05-22 |
2015-11-05 |
Genocea Biosciences Inc. |
Vaccines against Herpes Simplex Virus type 2: compositions and methods for eliciting an immune response
|
|
WO2011008548A1
(en)
|
2009-06-29 |
2011-01-20 |
Genocea Biosciences, Inc. |
Vaccines and compositions against streptococcus pneumoniae
|
|
CN102648003B
(zh)
|
2009-10-09 |
2016-01-13 |
儿童医疗中心有限公司 |
选择性裂解的全细胞疫苗
|
|
EP2335721A1
(en)
|
2009-12-21 |
2011-06-22 |
Institut Pasteur |
Streptavidin and Biotin-based antigen delivery system
|
|
US20110159040A1
(en)
|
2009-12-30 |
2011-06-30 |
Children's Medical Center Corporation |
Novel immunogens and methods for discovery and screening thereof
|
|
US20130115230A1
(en)
|
2010-04-30 |
2013-05-09 |
Augmenta Biologicals, Llc |
Delivery proteins
|
|
CA2849391A1
(en)
|
2010-10-20 |
2012-04-26 |
Genocea Biosciences, Inc. |
Chlamydia antigens and uses thereof
|
|
MX344120B
(es)
|
2011-01-20 |
2016-12-06 |
Genocea Biosciences Inc |
Vacunas y composiciones contra streptococcus pneumoniae.
|
|
AU2012253359B2
(en)
*
|
2011-05-11 |
2017-06-08 |
Children's Medical Center Corporation |
Multiple antigen presenting immunogenic composition, and methods and uses thereof
|
|
JP6379041B2
(ja)
|
2012-01-20 |
2018-08-22 |
ジェノセア バイオサイエンシーズ， インコーポレイテッド |
ストレプトコッカス・ニューモニエ（Ｓｔｒｅｐｔｏｃｏｃｃｕｓｐｎｅｕｍｏｎｉａｅ）に対する融合抗原ワクチンおよび組成物
|
|
WO2014018904A1
(en)
|
2012-07-26 |
2014-01-30 |
Genocea Biosciences, Inc. |
Fused antigen vaccines and compositions against streptococcus pneumoniae
|
|
CA2900008C
(en)
|
2013-02-07 |
2025-10-07 |
Children's Medical Center Corporation |
PROTEIN ANTIGENS THAT CONFER PROTECTION AGAINST COLONIZATION AND/OR PNEUMOCOCCAL DISEASE
|
|
EP3325008B1
(en)
|
2015-07-21 |
2025-09-10 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
|
|
KR102922338B1
(ko)
|
2018-09-12 |
2026-02-05 |
더 칠드런스 메디칼 센터 코포레이션 |
폐렴구균 융합 단백질 백신
|
|
TW202019470A
(zh)
|
2018-09-12 |
2020-06-01 |
美商艾芬尼維克斯公司 |
多價肺炎球菌疫苗
|